Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 11, 2025

Recent advances in neuroimaging of Alzheimer's disease and related dementias.

View Full Paper
Ask AI
Bookmark
Share

Authors

JOJulie OttoySunnybrook Health Science CentreNONicole OwsickiSunnybrook Health Science CentreMBMurat BilgelNational Institutes of Health

Discussion

Loading...

Member takes

Overview

Review discusses neuroimaging's role in tracking alzheimer's disease progression and validating biomarkers for better outcomes.

Key Points

  • Neuroimaging aids in visualizing and quantifying amyloid and tau levels in the brain, crucial for understanding alzheimer's disease.
  • Recent updates to alzheimer's disease diagnostic criteria in 2024 emphasize the importance of neuroimaging techniques and biomarkers.
  • Observational analysis reveals larger anti-amyloid drug effects when amyloid and tau levels are lower, highlighting treatment potential.
  • Advancements in radiotracer development for alpha-synuclein and tauopathies shows promise but challenges persist in tau PET imaging.

Cite This Study

Ottoy et al. (2025) studied this question.

synapsesocial.com/papers/68c2a9cb04ab598fffb89eb8https://doi.org/10.1002/alz.70648
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pathological Mechanisms and Molecular Imaging Advances in Alzheimer’s Disease2025 · 6 citations
  2. 2Potential diagnostic markers in Alzheimer's disease: current perspectives and future directions2025 · 5 citations
  3. 3Biomarkers and Stem Cell-based Therapeutics in Alzheimer’s Disease: Recent Advances and Future Directions2026
  4. 4Recent Advances in Understanding and Treating Alzheimer’s Disease2024
  5. 5From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer’s Disease Landscape2025 · 5 citations